跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Dizzinon Forte - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Dizzinon Forte
Approved
STANDARD
Dizzinon Forte
Lloyd Laboratories, Inc.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
9e342f23cc9389c3
Company
Lloyd Laboratories, Inc.
Type
Standard
Approval Details
Approval Id
9e342f23cc9389c3
Drug Approval Philippines Name
Dizzinon Forte
Product Name
Dizzinon Forte
Registration Number
DR-XY37385
Brand Name
Dizzinon Forte
Generic Name
Cinnarizine
Dosage Form
Capsule
Dosage Strength
75 mg
Manufacturer
Lloyd Laboratories, Inc.
Trader
Justright Healthcare Inc.
Issuance Date
27 September 2024
Expiry Date
21 January 2030
Pharmacologic Category
Anti-vertigo Preparation
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
9e342f23cc9389c3
Type
Standard
Back to Philippines FDA Approvals